STOCK TITAN

[SCHEDULE 13G/A] AVANOS MEDICAL, INC. Amended Passive Investment Disclosure

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Dimensional Fund Advisors LP filed an amended Schedule 13G reporting its beneficial ownership of Avanos Medical Inc common stock. Dimensional reports beneficial ownership of 2,157,531 shares of Avanos Medical, representing 4.6% of the outstanding common stock as of the event date 12/31/2025. It reports sole power to vote 2,087,813 shares and sole power to dispose of 2,157,531 shares, with no shared voting or dispositive power.

The shares are owned by various funds and accounts advised or managed by Dimensional or its subsidiaries, and Dimensional states that it may be deemed a beneficial owner because it has voting and/or investment power. Dimensional disclaims beneficial ownership of these securities and indicates that each underlying fund’s interest is below 5% of the class. The filing also certifies that the holdings are maintained in the ordinary course of business and not for the purpose of changing or influencing control of Avanos Medical.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Dimensional Fund Advisors LP
Signature:Selwyn Notelovitz
Name/Title:Global Chief Compliance Officer
Date:01/21/2026
Avanos Medical

NYSE:AVNS

AVNS Rankings

AVNS Latest News

AVNS Latest SEC Filings

AVNS Stock Data

598.34M
44.55M
4.07%
98.38%
5.89%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
ALPHARETTA